Characterization	O
of	O
transferrin	O
glycoforms	O
in	O
human	O
serum	B-Organism_substance
by	O
CE	O
-	O
UV	O
and	O
CE	O
-	O
ESI	O
-	O
MS	O
.	O

Human	O
transferrin	O
(	O
Tf	O
)	O
is	O
a	O
model	O
glycoprotein	O
for	O
congenital	O
disorders	O
of	O
glycosylation	O
(	O
CDG	O
)	O
diagnosis	O
.	O

In	O
the	O
last	O
few	O
years	O
,	O
new	O
CE	O
-	O
UV	O
methods	O
for	O
intact	O
Tf	O
glycoforms	O
analysis	O
have	O
been	O
developed	O
using	O
nonvolatile	O
BGEs	O
and	O
organic	O
modifiers	O
.	O

However	O
,	O
the	O
use	O
of	O
these	O
BGEs	O
does	O
not	O
allow	O
the	O
coupling	O
of	O
these	O
procedures	O
with	O
electrospray	O
MS	O
(	O
ESI	O
-	O
MS	O
)	O
.	O

In	O
this	O
study	O
,	O
a	O
new	O
CE	O
-	O
UV	O
separation	O
method	O
of	O
Tf	O
glycoforms	O
is	O
developed	O
,	O
using	O
a	O
double	O
-	O
layer	O
stable	O
coating	O
and	O
a	O
volatile	O
BGE	O
based	O
on	O
ammonium	O
acetate	O
.	O

The	O
separation	O
method	O
is	O
optimized	O
using	O
standard	O
Tf	O
and	O
their	O
potential	O
is	O
demonstrated	O
applying	O
the	O
method	O
to	O
the	O
analysis	O
of	O
sera	B-Organism_substance
Tf	O
from	O
healthy	O
individuals	O
and	O
CDG	O
patients	O
.	O

The	O
CE	O
-	O
UV	O
separation	O
method	O
has	O
been	O
coupled	O
to	O
ESI	O
-	O
MS	O
detection	O
.	O

Main	O
parameters	O
such	O
as	O
sheath	O
liquid	O
composition	O
are	O
optimized	O
in	O
order	O
to	O
obtain	O
a	O
good	O
sensitivity	O
.	O

The	O
CE	O
-	O
ESI	O
-	O
MS	O
method	O
has	O
also	O
been	O
used	O
in	O
serum	B-Organism_substance
samples	I-Organism_substance
obtaining	O
the	O
separation	O
of	O
the	O
different	O
proteins	O
present	O
in	O
serum	B-Organism_substance
and	O
partial	O
separation	O
of	O
Tf	O
glycoforms	O
.	O

Different	O
mass	O
spectra	O
and	O
deconvoluted	O
molecular	O
masses	O
were	O
obtained	O
for	O
each	O
sialoform	O
,	O
allowing	O
unequivocal	O
glycoform	O
identification	O
.	O

